Volume 10, Number 9—September 2004

Perspective

Potential Public Health Impact of New Tuberculosis Vaccines

Elad Ziv*, Charles L. Daley*†, and Sally Blower‡ 

Author affiliations: *University of California—San Francisco, San Francisco, California, USA; †San Francisco General Hospital, San Francisco, California, USA; ‡David Geffen School of Medicine at UCLA, Los Angeles California, USA

Main Article

Figure 2

Figure 2. Flow-diagram of preexposure tuberculosis (TB) vaccine model. States and processes that relate to the vaccine are shown in red. Equations are given in the Appendix.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.